# Wave 1C -- Commercial Release-Gate Re-Audit, Paid-Pilot Verdict, and Owner-Platform Entry Decision

## 1. Executive verdict
Both Aura Retail and Aura Clinic, on both platforms, **clear Gate 1 (Internal Testing), Gate 2 (Controlled Pilot), and Gate 3 (Controlled Paid Pilot)** as of this wave -- Clinic Android unconditionally, every other product/platform combination with explicit, enforceable, disclosed conditions (Windows: unsigned-artifact disclosure; Retail: hardware-claim scoping). **Neither product clears Gate 4 (General Paid SMB Release) or Gate 5 (Enterprise Grade).** This is a fundamentally different picture from the pre-Wave-0 baseline audit, where nothing cleared Gate 2 at all -- every one of the ten originally-named release-blocking defects has since been fixed, and the entire P0/P1 set was independently, adversarially re-proven this wave, not merely re-read from prior reports. **Recommendation: proceed to a real first paid pilot with Aura Clinic.**

## 2. Exact release candidates evaluated
- Aura Retail Windows 1.0.0-rc.1 (`AuraRetail-Setup-1.0.0-rc.1.exe`)
- Aura Retail Android 1.0.0-rc.1 (versionCode 2)
- Aura Clinic Windows 1.0.0-rc.1 (`AuraClinic-Setup-1.0.0-rc.1.exe`)
- Aura Clinic Android 1.0.0-rc.1 (versionCode 2)

All four traced to tag `commercial-packaging-wave1b-complete`, commit `157521c46bc89dee10d44dd097534fce7461d135`. All six binary artifacts (2 installers, 2 APKs, 2 AABs) re-checksummed at audit start: **100% match** to the Wave 1B manifest -- zero drift. Android artifacts additionally freshly rebuilt from source this wave and found **bit-identical** to the shipped binaries.

## 3. Tests executed
**382 automated test executions this wave, 382 passed, 0 failed, 0 skipped**: 285 Python backend (18 files) + 12 new Wave 1C adversarial financial tests (2 new files) + 36 Android Retail + 49 Android Clinic. Plus a full hands-on Windows install/upgrade/uninstall/reinstall/crash-recovery lifecycle pass, and two independent manual backup/restore adversarial tests (corrupted archive rejected, cross-product restore rejected) outside the pytest suite. No mandatory suite was skipped. Full detail: `automated-regression-report.md`.

## 4. Retail Windows gate results
Gate 1 PASS, Gate 2 PASS, Gate 3 **CONDITIONAL PASS** (unsigned-artifact six-point disclosure + supervised install + hardware-claim scoping), Gate 4 FAIL, Gate 5 FAIL. Full lifecycle (install/upgrade/uninstall/reinstall/hard-kill crash recovery) re-proven this wave with zero defects found. Detail: `windows-release-gate-report.md`.

## 5. Retail Android gate results
Gate 1 PASS, Gate 2 PASS, Gate 3 **CONDITIONAL PASS** (hardware-claim scoping to physically-verified camera scanning only), Gate 4 FAIL, Gate 5 FAIL. 36/36 unit tests, clean lint, bit-identical signed rebuild, certificate-verified. Detail: `android-release-gate-report.md`.

## 6. Retail overall classification and score
**Commercial readiness: 67/100 -- "Commercially usable for small customers with limitations."** **Enterprise readiness: 21/100.** Detail: `commercial-and-enterprise-scorecard.md`.

## 7. Clinic Windows gate results
Gate 1 PASS, Gate 2 PASS, Gate 3 **CONDITIONAL PASS** (unsigned-artifact disclosure + supervised install; no hardware condition), Gate 4 FAIL, Gate 5 FAIL. Detail: `windows-release-gate-report.md`.

## 8. Clinic Android gate results
Gate 1 PASS, Gate 2 PASS, Gate 3 **PASS -- unconditional on hardware** (no scanner/printer dependency), still subject to the shared supervised-support term. Gate 4 FAIL, Gate 5 FAIL. 49/49 unit tests, clean lint, bit-identical signed rebuild. Detail: `android-release-gate-report.md`.

## 9. Clinic overall classification and score
**Commercial readiness: 73/100 -- "Commercially usable for small customers with limitations,"** the strongest platform/product combination evaluated. **Enterprise readiness: 25/100.** Detail: `commercial-and-enterprise-scorecard.md`.

## 10. Financial verdict
**PASS, both products.** 12/12 fresh adversarial cases (4 Retail, 8 Clinic) independently proven against the live backend this wave -- server-authoritative pricing/tax/discount, manipulated-client-total rejection, idempotency collapse under retry, over-return/over-payment rejection, and (Clinic) a fault-injected transaction-rollback proof. Zero financial defects found. Detail: `financial-release-gate-report.md`.

## 11. Data-loss verdict
**PASS, both products.** Full Windows lifecycle (install/upgrade/uninstall-preserves-data/reinstall-no-re-onboarding/hard-kill crash recovery) hands-on re-proven this wave with zero defects; Android upgrade preservation rests on Wave 1A's physical-device proof against artifacts confirmed bit-identical to what's evaluated here. Detail: `data-integrity-and-zero-loss-gate.md`.

## 12. Backup/recovery verdict
**PASS, both products.** Automated suite (12+4 tests) plus fresh manual adversarial tests this wave: corrupted backup rejected, cross-product restore rejected, both confirmed live against the running backend. Detail: `backup-and-recovery-gate.md`.

## 13. Security verdict
**PASS, both products.** 18-point fresh code-level re-check this wave found zero new issues; REL-006 (cross-product port race) and SEC-001 (receipt XSS) both independently reconfirmed still fixed. Detail: `security-release-gate.md`.

## 14. Privacy verdict
**PASS, Clinic**, with two disclosed, pre-existing, deliberately-documented limitations (secretary read access to clinical notes, session-version staleness on role demotion) -- neither new, neither P0/P1, both explained in `docs/security/clinic-rbac-matrix.md` and carried into the pilot-agreement terms. Detail: `clinic-privacy-release-gate.md`.

## 15. Windows signing impact
Unsigned installers/executables do not block installation and are not an unavoidable hard SmartScreen block, but are an unacceptable trust risk for **unsupervised** distribution. Per this wave's own governing rule, this is a **CONDITIONAL PASS for Controlled Paid Pilot** (six explicit, disclosed, enforceable conditions) and a **FAIL/blocker for General Paid SMB Release** until a trusted Authenticode certificate is purchased and applied via the already-prepared `sign_windows_release.ps1`. Detail: `windows-release-gate-report.md`.

## 16. Android signing verdict
**PASS, both products.** Fresh signed rebuild this wave, `apksigner verify` exit 0, certificate fingerprints match the recorded production-signing policy exactly, artifacts bit-identical to what's already shipped.

## 17. Hardware verdict
Only **Android camera-based barcode scanning** is physically device-verified. Windows/Android HID scanning is protocol-supported and unit-tested but never run against real scanner hardware. Windows OS-spooler printing serves correctly but has never been click-tested through a real print dialog/printer. No direct ESC/POS, Bluetooth/USB thermal printing, or vendor-SDK scanning exists. Clinic has no hardware dependency of any kind. Detail: `hardware-commercial-claim-review.md`.

## 18. Controlled-pilot verdict
**PASS, both products, both platforms** (Gate 2). No unresolved financial, data-integrity, security, or privacy P0/P1 exists for either product.

## 19. Paid-pilot verdict
**CONDITIONAL PASS**, both products (Gate 3) -- Clinic Android unconditional on hardware; every other combination gated on explicit, disclosed, enforceable pilot-agreement terms (unsigned-Windows disclosure, supervised support, hardware-claim scoping where applicable). See `first-paid-pilot-profile.md` for the exact terms.

## 20. General SMB-release verdict
**FAIL, both products, all platforms** (Gate 4). Blocked on: Windows signing, absence of self-service customer documentation/support process, and (Retail only) unverified scanner/printer hardware for an unqualified compatibility claim. No material P0/P1 blocks this gate -- everything blocking it is a trust/documentation/hardware-verification gap, not a code defect.

## 21. Enterprise-grade verdict
**FAIL, both products, decisively** (Gate 5). Enterprise readiness scores 20-26/100 across every platform -- no observability, no controlled-update mechanism, no formal disaster-recovery drills, no scale evidence beyond a historical ~5,000-row test, no SLA/support tiering, no Owner/licensing governance. This gap is not close and should not be described as close.

## 22. First-customer profile
**Aura Clinic**: a single small independent clinic (1-3 doctors), Windows-primary, founder-supervised install/support, daily backup verification, no unsupervised upgrades, 4-6 week pilot, explicit acknowledgement of the disclosed RBAC-read and Windows-signing limitations. **Aura Retail** (second, later pilot): a single store/single till, contingent on the team personally verifying that specific customer's scanner/printer hardware before relying on it. Full terms: `first-paid-pilot-profile.md`.

## 23. Launch-order recommendation
**Launch Aura Clinic first.** Not a feature-count decision -- Clinic has zero external hardware dependency standing between "the software is ready" and "a real customer can use it," while Retail's realistic minimum pilot depends on scanner/printer hardware that has never been verified beyond one Android camera-scanning pass. Retail follows once a specific pilot customer's hardware has been personally verified by the team. Parallel launch is not recommended (support-capacity split); "launch neither yet" is explicitly rejected (both products clear every P0/P1-relevant gate). Detail: `launch-order-recommendation.md`.

## 24. Remaining blockers
**For General Paid SMB Release** (not for the paid pilot): Windows code signing (business decision, not engineering -- guide and script ready), self-service customer documentation and a real support/escalation process (none exist), and, for Retail specifically, physical scanner/printer hardware verification beyond the one Android-camera pass already done. **No P0 or P1 defect remains unresolved for either product** as of this wave's re-audit.

## 25. Acceptable pilot limitations
Unsigned Windows artifacts (disclosed, supervised); Clinic's secretary-can-read-clinical-notes model (deliberate, documented source behavior, disclosed to the customer); single-device-model UX testing to date; Windows receipt printing not click-tested through a real dialog (Retail pilot only, team must personally verify with the customer's actual printer); no self-service documentation (substituted with founder-supervised support for the pilot's duration).

## 26. Owner-platform entry decision
**YES.** All ten of the spec's own conditions are met -- Clinic clears Controlled Paid Pilot, has a stable versioned identity, signed Android artifacts, an understood Windows install state, complete data independence from any Owner system, zero unresolved P0/P1, and a clean architectural seam (`commercial_runtime/`) for adding a licensing adapter without touching product financial/patient logic. Scope: **Owner Foundation Only** (staff auth/roles, product/plan/customer/subscription catalog, license generation/status, device registration, activation events, renewal/expiration, audit log, secure API contracts) -- explicitly no customer financial/medical data flow, no telemetry beyond license metadata, no remote database access, no remote destructive actions, and **no licensing enforcement wired into either product yet** (a separate, later, its-own-gate-review decision). Detail: `owner-platform-entry-decision.md`.

## 27. Exact next phase
No Wave 1D work begins automatically. Per this wave's own governing instruction, **Wave 1C stops here.** The next phase is a business/execution decision by the founder: begin the Aura Clinic Controlled Paid Pilot under the terms in `first-paid-pilot-profile.md`, and/or begin Owner Foundation development under the scope in `owner-platform-entry-decision.md`. Neither is started by this document.

---

## Files created this wave
```
docs/release/wave1c/wave1c-audit-scope.md
docs/release/wave1c/release-candidate-identity-verification.md
docs/release/wave1c/evidence-index.md
docs/release/wave1c/automated-regression-report.md
docs/release/wave1c/financial-release-gate-report.md
docs/release/wave1c/data-integrity-and-zero-loss-gate.md
docs/release/wave1c/backup-and-recovery-gate.md
docs/release/wave1c/windows-release-gate-report.md
docs/release/wave1c/android-release-gate-report.md
docs/release/wave1c/hardware-commercial-claim-review.md
docs/release/wave1c/security-release-gate.md
docs/release/wave1c/clinic-privacy-release-gate.md
docs/release/wave1c/localization-and-ux-gate.md
docs/release/wave1c/operational-supportability-gate.md
docs/release/wave1c/release-gate-scorecard.md
docs/release/wave1c/commercial-and-enterprise-scorecard.md
docs/release/wave1c/first-paid-pilot-profile.md
docs/release/wave1c/owner-platform-entry-decision.md
docs/release/wave1c/wave1c-residual-risk-register.md
docs/release/wave1c/launch-order-recommendation.md
docs/release/wave1c/WAVE1C-COMMERCIAL-RELEASE-DECISION.md   (this document)
```
Plus two new audit-only test files: `products/retail/tests/wave1c_financial_gate_test.py`, `products/clinic/tests/wave1c_financial_gate_test.py`. Plus updates to `docs/audit/22-master-defect-registry.{md,json,csv}` (Wave 1C status added per issue, nothing removed).

## What this wave does not claim
Neither product is described anywhere in this document set as commercially ready, production ready, enterprise grade, safe for general paid customers, or universally compatible with all scanners/printers. Every PASS/CONDITIONAL PASS/FAIL verdict above is scoped exactly to what was independently re-verified this wave, with evidence, not assumed from a prior wave's word.
